Health in El Salvador 1,364 indicators covering health for El Salvador. IndicatorLatest Year10-yr change Rank Bladder cancer death rate 0.5396 deaths per 100,000 people 2018 up 8.7% 105th Cancer death rates by type 0.5396 deaths per 100,000 people 2018 up 8.7% 105th Weight-for-height <-2 SD 2.9 2021 up 82.7% 68th Deaths from earthquakes 1 deaths 2019 unchanged 37th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 99.0% 2025 — 1st International Health Regulations core capacity scores, SPAR version 80 2025 — 25th Prevalence of underweight, weight for age 5.0% 2021 down 25.4% 60th Leprosy registered prevalence rate per 1 000 000 population 0.473 2024 down 39.6% 97th Leprosy - Number of new leprosy cases among children 0 2024 — 69th Leprosy - Number of cases registered for treatment 3 2024 down 40.0% 102nd New leprosy child case detection rate (less than 15 years of age) per 0 2024 — 69th Children (0-14) living with HIV 500 2024 unchanged 66th Deaths in armed conflicts, annual growth rate -100 % change on previous year 2023 unchanged 46th Number of one-year-olds who have not received the inactivated polio vaccine 3,950 one-year-olds 2023 up 249.6% 116th Children living with HIV 500 0-14 2024 unchanged 66th Contraceptive prevalence, any method 53.6% 2021 down 26.1% 65th Children (ages 0-14) newly infected with HIV 100 2024 unchanged 51st Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Age-standardized prevalence of current tobacco use among persons aged 8.2% 2024 down 20.4% 135th Liver cancer death rate 4 deaths per 100,000 people 2018 down 7.8% 63rd Annual number of children newly infected with HIV 100 ages 0-14 2024 unchanged 51st Children newly infected with HIV 27.01 infections 2024 down 10.8% 74th Number of female leprosy new cases 0 2024 down 100.0% 102nd Estimated number of malaria deaths 0 2024 — 66th Estimated number of malaria cases 0 2024 down 100.0% 82nd National smoking ban: NUMBER OF PLACES SMOKE-FREE 8 2022 — 1st Contraceptive prevalence, any modern method 52.1% 2021 down 21.3% 46th Number of prevalent tuberculosis cases 3,000 2014 up 42.9% 109th Estimated malaria incidence 0 2024 down 100.0% 82nd Estimated malaria mortality rate 0 2024 — 66th Number of new G2D leprosy cases 3 2024 — 66th Leprosy - New leprosy cases with G2D rate per 1 000 000 population 0.473 2024 — 58th 3.7.2 Adolescent birth rate per 1,000 women 50 2018 down 29.3% 67th Rate of deaths and missing persons due to natural disasters 0.54 per 100,000 population 2023 up 237.5% 72nd Proportion of total government spending on essential services, health 18.6% 2024 up 101.4% 10th 3.1.2 Proportion of births attended by skilled health personnel 100 2018 up 4.7% 1st Pancreatic cancer death rate 1.83 deaths per 100,000 people 2018 down 19.6% 104th Brain and nervous system cancer death rate 2.52 deaths per 100,000 people 2018 up 10.6% 71st Inflation-adjusted prices for most sold brand of cigarettes: Prices 7.49 2022 up 58.0% 72nd Taxes as a % of price: total tax 45.7% 2022 down 13.7% 120th Taxes as a % of price: ad valorem excise 21.2% 2022 up 15.4% 59th Taxes as a % of price: specific excise 13.0% 2022 down 43.6% 117th Taxes as a % of price: import duties 0.0% 2022 — 38th Taxes as a % of price: other taxes 0.0% 2022 — 57th Taxes as a % of price: value added tax 11.5% 2022 unchanged 111th Inflation-adjusted prices for most sold brand of cigarettes: Price in 3.46 2022 up 54.5% 168th Estimated number of children needing antiretroviral therapy based on 500 2025 down 9.1% 64th Weight-for-height <-3 SD 0.7 2021 up 48.6% 57th Prevalence of severe wasting, weight for height 0.7% 2021 up 40.0% 56th Physical activity policies for activie societies 20 2023 unchanged 2nd Physical activity policies focused on active systems 10 2023 down 50.0% 101st Number of deaths from malaria 0 Deaths 2024 — 66th Cholera case-fatality rate 0.3% 2000 down 91.2% 46th Death rate from malaria 0 Deaths 2024 — 66th New cases of malaria per 1,000 people at risk 0 per 1,000 population at risk 2024 — 79th Share of one-year-olds vaccinated against Streptococcus pneumoniae 96.0% 2024 up 9.1% 15th Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage 96.0% 2024 up 9.1% 15th Estimated antiretroviral therapy coverage among children 26 2025 down 48.0% 76th Child population under age 5 487.74 2025 down 14.6% 16th Percentage of children as a proportion of total population 29.66 2025 down 16.4% 12th ← Previous Page 19 of 23 Next →